VEGFA and endophthalmitis: Anti-VEGF agents like ranibizumab and aflibercept reduce vascular permeability but can cause complications such as increased intraocular pressure (IOP) and endophthalmitis, while corticosteroids like dexamethasone and triamcinolone reduce inflammation but can lead to cataracts, increased IOP, and endophthalmitis [6-9].